X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (342) 342
Conference Proceeding (28) 28
Book Review (21) 21
Publication (18) 18
Book Chapter (6) 6
Book / eBook (4) 4
Patent (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (162) 162
index medicus (149) 149
humans (143) 143
female (101) 101
middle aged (80) 80
male (79) 79
aged (69) 69
adult (66) 66
chemotherapy (57) 57
cancer (53) 53
prognosis (43) 43
survival (37) 37
hematology (36) 36
aged, 80 and over (32) 32
lung cancer (32) 32
medicine & public health (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
care and treatment (27) 27
treatment outcome (26) 26
lung neoplasms - drug therapy (22) 22
neoplasm staging (22) 22
adolescent (20) 20
breast cancer (20) 20
breast neoplasms - genetics (20) 20
survival rate (20) 20
disease-free survival (19) 19
lung cancer, non-small cell (19) 19
risk (19) 19
antineoplastic agents - therapeutic use (18) 18
carcinoma, non-small-cell lung - drug therapy (18) 18
rituximab (18) 18
lung neoplasms - pathology (17) 17
mutation (17) 17
respiratory system (17) 17
risk factors (17) 17
analysis (16) 16
hematology, oncology and palliative medicine (16) 16
lung neoplasms - genetics (16) 16
young adult (16) 16
expression (15) 15
patients (15) 15
research (15) 15
tumors (15) 15
breast neoplasms - pathology (14) 14
cisplatin (14) 14
disease (14) 14
internal medicine (14) 14
lymphoma (14) 14
lymphomas (14) 14
prospective studies (14) 14
deoxycytidine - analogs & derivatives (13) 13
epidemiology (13) 13
hodgkin's disease (13) 13
loss of heterozygosity (13) 13
mutations (13) 13
carcinoma, non-small-cell lung - genetics (12) 12
carcinoma, non-small-cell lung - pathology (12) 12
follicular lymphoma (12) 12
kaplan-meier estimate (12) 12
medicina (12) 12
trial (12) 12
follow-up studies (11) 11
lung neoplasms - mortality (11) 11
metastasis (11) 11
oncology, experimental (11) 11
pulmonary/respiratory (11) 11
spain (11) 11
breast-cancer (10) 10
carcinoma, non-small-cell lung - mortality (10) 10
case-control studies (10) 10
cell biology (10) 10
cisplatin - administration & dosage (10) 10
genetic aspects (10) 10
genetics & heredity (10) 10
medicine (10) 10
pathology (10) 10
radiotherapy (10) 10
smoking (10) 10
survival analysis (10) 10
therapy (10) 10
animals (9) 9
antineoplastic agents (9) 9
apoptosis (9) 9
cancer therapies (9) 9
deoxycytidine - administration & dosage (9) 9
drug therapy (9) 9
follow-up (9) 9
gene expression regulation, neoplastic (9) 9
immunotherapy (9) 9
medicine, general & internal (9) 9
non-hodgkins-lymphoma (9) 9
non-small-cell lung cancer (9) 9
patient outcomes (9) 9
polymerase chain reaction (9) 9
prevalence (9) 9
prognostic factors (9) 9
recurrence (9) 9
spain - epidemiology (9) 9
vinorelbine (9) 9
angiogenesis (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1997, Biblioteca EDAF, ISBN 8441402663, Volume 220, 446
Book
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 328 - 337
Journal Article
ANALES RANM, ISSN 0034-0634, 05/2019, Volume 136, Issue 1, pp. 17 - 24
Journal Article
by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 10, pp. 958 - 967
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e98169 - e98169
Journal Article
PLoS ONE, ISSN 1932-6203, 2009, Volume 4, Issue 5, pp. e5133 - e5133
Journal Article